Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kira Bettermann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|June 5, 2014
Steatosis and steatohepatitis: complex disordersKira Bettermann, Tabea Hohensee, Johannes Haybaeck
Hepatitis Monthly|December 13, 2012
Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?Elisabeth Smolle, Evelyn Zöhrer, Kira Bettermann, et al.
Cancer Letters|December 6, 2011
SUMOylation in carcinogenesisKira Bettermann, Martin Benesch, Serge Weis, et al.
Oncotarget|February 11, 2011
Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?Mihael Vucur, Christoph Roderburg, Kira Bettermann, et al.
International Journal of Cancer|March 5, 2019
Targeting RIPK1 in AML cells carrying FLT3-ITDLaura K Hillert, Kira Bettermann-Bethge, Subbaiah Chary Nimmagadda, et al.
Human Pathology|December 20, 2011
NEMO expression in human hepatocellular carcinoma and its association with clinical outcomeAriane Aigelsreiter, Johannes Haybaeck, Silvia Schauer, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisChristoph Roderburg, Gerd-Willem Urban, Kira Bettermann, et al.
Oncotarget|October 1, 2016
Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesisKira Bettermann, Anita Kuldeep Mehta, Eva M Hofer, et al.
Cancer Cell|May 19, 2010
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancerKira Bettermann, Mihael Vucur, Johannes Haybaeck, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|June 5, 2014
Steatosis and steatohepatitis: complex disordersKira Bettermann, Tabea Hohensee, Johannes Haybaeck
Hepatitis Monthly|December 13, 2012
Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?Elisabeth Smolle, Evelyn Zöhrer, Kira Bettermann, et al.
Cancer Letters|December 6, 2011
SUMOylation in carcinogenesisKira Bettermann, Martin Benesch, Serge Weis, et al.
Oncotarget|February 11, 2011
Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?Mihael Vucur, Christoph Roderburg, Kira Bettermann, et al.
International Journal of Cancer|March 5, 2019
Targeting RIPK1 in AML cells carrying FLT3-ITDLaura K Hillert, Kira Bettermann-Bethge, Subbaiah Chary Nimmagadda, et al.
Human Pathology|December 20, 2011
NEMO expression in human hepatocellular carcinoma and its association with clinical outcomeAriane Aigelsreiter, Johannes Haybaeck, Silvia Schauer, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisChristoph Roderburg, Gerd-Willem Urban, Kira Bettermann, et al.
Oncotarget|October 1, 2016
Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesisKira Bettermann, Anita Kuldeep Mehta, Eva M Hofer, et al.
Cancer Cell|May 19, 2010
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancerKira Bettermann, Mihael Vucur, Johannes Haybaeck, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
Pageof 2